loadpatents
Patent applications and USPTO patent grants for Leusen; Jeannette Henrica Wilhelmina.The latest application filed is for "treating pathological conditions by direct and indirect targeting of sirpa-cd47 interaction".
Patent | Date |
---|---|
CD20 antibodies Grant 11,414,495 - Leusen , et al. August 16, 2 | 2022-08-16 |
Treating Pathological Conditions By Direct And Indirect Targeting Of Sirpa-cd47 Interaction App 20220087981 - Raaben; Matthijs ;   et al. | 2022-03-24 |
COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS App 20210332131 - De Boer; Mark ;   et al. | 2021-10-28 |
IgA mediated killing of aberrant cells by CD47- SIRPalpha checkpoint inhibition of neutrophils App 20210324073 - LEUSEN; Jeannette Henrica Wilhelmina | 2021-10-21 |
Treating Pathological Conditions By Direct And Indirect Targeting Of Sirpa-cd47 Interaction App 20190365717 - RAABEN; Matthijs ;   et al. | 2019-12-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.